These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8707748)

  • 1. Comparative in-vitro activity of SCH 27899, a novel everninomicin, and vancomycin.
    Urban C; Mariano N; Mosinka-Snipas K; Wadee C; Chahrour T; Rahal JJ
    J Antimicrob Chemother; 1996 Feb; 37(2):361-4. PubMed ID: 8707748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative in-vitro activity of LY146032 a new peptolide, with vancomycin and eight other agents against gram-positive organisms.
    Benson CA; Beaudette F; Trenholm G
    J Antimicrob Chemother; 1987 Aug; 20(2):191-6. PubMed ID: 2822645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Everninomicin, a new oligosaccharide antibiotic: its antimicrobial activity, post-antibiotic effect and synergistic bactericidal activity.
    Nakashio S; Iwasawa H; Dun FY; Kanemitsu K; Shimada J
    Drugs Exp Clin Res; 1995; 21(1):7-16. PubMed ID: 7796712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary interpretive criteria for disk diffusion susceptibility testing of SCH 27899, a compound in the everninomicin class of antimicrobial agents.
    Cormican MG; Marshall SA; Jones RN
    Diagn Microbiol Infect Dis; 1995 Dec; 23(4):157-60. PubMed ID: 9407222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of telavancin compared with vancomycin and linezolid against Gram-positive organisms isolated from cancer patients.
    Rolston K; Wang W; Nesher L; Coyle E; Shelburne S; Prince RA
    J Antibiot (Tokyo); 2014 Jul; 67(7):505-9. PubMed ID: 24824818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic and bacteriologic properties of SCH-27899 (Ziracin), an investigational antibiotic from the everninomicin family.
    Foster DR; Rybak MJ
    Pharmacotherapy; 1999 Oct; 19(10):1111-7. PubMed ID: 10512059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of mersacidin (M87-1551), an investigational peptide antibiotic tested against gram-positive bloodstream isolates.
    Barrett MS; Wenzel RP; Jones RN
    Diagn Microbiol Infect Dis; 1992; 15(7):641-4. PubMed ID: 1424522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the in vitro antibacterial activity of teicoplanin and vancomycin against gram-positive cocci.
    Ravizzola G; Pirali F; Foresti I; Turano A
    Drugs Exp Clin Res; 1987; 13(4):225-9. PubMed ID: 2957187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the in-vitro activity of the glycopeptide antibiotic LY333328 in comparison with vancomycin and teicoplanin.
    Harland S; Tebbs SE; Elliott TS
    J Antimicrob Chemother; 1998 Feb; 41(2):273-6. PubMed ID: 9533471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro Gram-positive antimicrobial activity of evernimicin (SCH 27899), a novel oligosaccharide, compared with other antimicrobials: a multicentre international trial.
    Jones RN; Hare RS; Sabatelli FJ;
    J Antimicrob Chemother; 2001 Jan; 47(1):15-25. PubMed ID: 11152427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of 43 antimicrobial agents tested against ampicillin-resistant enterococci and gram-positive species resistant to vancomycin.
    Yamane N; Jones RN
    Diagn Microbiol Infect Dis; 1991; 14(4):337-45. PubMed ID: 1889183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro activities of daptomycin, linezolid, and quinupristin/dalfopristin against Gram-positive bacterial isolates from a large cancer center.
    Smith PF; Booker BM; Ogundele AB; Kelchin P
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):255-9. PubMed ID: 15935606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of dalbavancin and five comparator agents against common and uncommon Gram-positive organisms isolated from cancer patients.
    Rolston KV; Wang W; Nesher L; Shelburne SA; Prince RA
    J Antibiot (Tokyo); 2016 May; 69(5):381-7. PubMed ID: 26626876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of quinupristin/dalfopristin, RP59500, against gram-positive clinical isolates.
    Qadri SM; Ueno Y; Abu Mostafa FM; Halim M
    Chemotherapy; 1997; 43(2):94-9. PubMed ID: 9084917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vitro activities of teicoplanin, vancomycin, oxacillin, and other antimicrobial agents against bacteremic isolates of gram-positive cocci.
    Gorzynski EA; Amsterdam D; Beam TR; Rotstein C
    Antimicrob Agents Chemother; 1989 Nov; 33(11):2019-22. PubMed ID: 2532875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiological characterization of dactimicin: antibacterial activity towards gram-positive and gram-negative bacteria.
    Stefani S; Debbia EA; Schito GC; Russo G
    Drugs Exp Clin Res; 1989; 15(3):119-23. PubMed ID: 2752910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in-vitro activities of RP59500 (quinupristin/dalfopristin), CL 329,998, CL 331,002, trovafloxacin, clinafloxacin, teicoplanin and vancomycin against Gram-positive bacteria.
    Shonekan D; Handwerger S; Mildvan D
    J Antimicrob Chemother; 1997 Mar; 39(3):405-9. PubMed ID: 9096191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of telavancin against gram-positive clinical isolates recently obtained in Europe.
    Jansen WT; Verel A; Verhoef J; Milatovic D
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3420-4. PubMed ID: 17606689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of ramoplanin against vancomycin-resistant gram-positive organisms.
    Collins LA; Eliopoulos GM; Wennersten CB; Ferraro MJ; Moellering RC
    Antimicrob Agents Chemother; 1993 Jun; 37(6):1364-6. PubMed ID: 8328787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antimicrobial spectrum of dalbavancin. Mechanism of action and in vitro activity against Gram-positive microorganisms].
    Cercenado E
    Enferm Infecc Microbiol Clin; 2017 Jan; 35 Suppl 1():9-14. PubMed ID: 28129822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.